Page 69 - Ethical Guidelines for Conducting Research Studies Involving Human Subjects
P. 69

Pre-implantation  genetic  diagnosis (PGD  or  PIGD)  is
                                 genetic profiling  of   embryos  or  oocytes   prior  to  implantation  or
                                 fertilization.PGD  thus  is  an  adjunct  to assisted  reproductive
                                 technology  and  in  vitro  fertilization (IVF)  to  obtain oocytes  or
                                 embryos for  evaluation.PGD  is  considered  in  a  similar  fashion  to
                                 prenatal diagnosis.

                                 The role of prenatal diagnosis is needed or managing the remaining
                                 weeks of the pregnancy, determining the outcome of the pregnancy,
                                 planning  for  possible  complications  with  the  birth  process  and  in
                                 the  newborn  infant,  deciding  whether  to  continue  the  pregnancy
                                 and finding conditions that may affect future pregnancies.

                                 There  are  a  variety  of  non-invasive  and  invasive  techniques
                                 available  for  prenatal  diagnosis  such  as  ultrasonography,
                                 amniocentesis,  chorionic  villus  sampling,  genetic  analyses  of  fetal
                                 blood cells in maternal blood and biochemical analyses of maternal
                                 serum. Methods employed for analysis of fetal and placental tissues
                                 include pathological examination of the fetus or fetal parts and the
                                 placenta,  radiography,  microbiologic  culture,  biochemical  analysis,
                                 karyotyping, fluorescence in situ hybridization (FISH), DNA probes
                                 etc.

                                 As  with  all  medical  interventions  associated  with  human
                                 reproduction, PGD raises strong, often conflicting opinions of social
                                 acceptability,  particularly  due  to  its  eugenic implications.  For
                                 example,  in  Germany  the  use  of  PGD  had  been  prohibited  by  an
                                 Embryo Protection Act, though this prohibition was partly relaxed
                                 later. In other countries PGD is permitted in law but its operation
                                 is controlled by the state.

                                 PGD  can  potentially  be  used  to  select  embryos  without  a  genetic
                                 defect, to have increased chances of successful pregnancy, to match
                                 a  sibling  in  HLA  type in  order  to  be  a  donor,  to  have  less  cancer
                                 predisposition, and for sex selection.

                                 Sex selection is indicated only in X linked disorders where male are
                                 the sufferers.  However, due to prevailing inclination for male child
                                 in  many  societies,  prenatal  sex  determination  other  than  strong
                                 medical indication should not be allowed.

                                 Several genetic disorders can be detected in utero but do not have
                                 satisfactory  treatment  or  cures.  Presently,  the  detection  and
                                 elimination of genetic disorders generally relies on a combination of
                                 prenatal  diagnosis  plus  abortion  of  an  affected  fetus.  Many
                                 individuals,  regardless  of  their  views  regarding  abortion,  consider
                                 prenatal diagnosis plus abortion a less than optimal solution to the
                                 problem of genetic disease.



                   BMRC ETHICAL GUIDELINE ON HUMAN SUBJECTS                                   Page 65
   64   65   66   67   68   69   70   71   72   73   74